Skip to Main Content
S. Karger AG
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 134, Issue 4
November 2015
Issue Cover
All Issues
ISSN 0001-5792
EISSN 1421-9662

Acta Haematologica 2015, Vol. 134, No. 4

Original Paper

PRAME Expression and Its Clinical Relevance in Hodgkin's Lymphoma
Topic Article Package: Topic Article Package: Melanoma
Subject Area: Hematology , Oncology
Vehbi Ercolak; Semra Paydas; Emine Bagir; Melek Ergin; Gulsah Seydaoglu; Hikmet Celik; Basak Yavuz; Kahraman Tanriverdi; Meral Gunaldi; Cigdem U. Afsar; Berna B. Duman
Acta Haematol (2015) 134 (4): 199–207. https://doi.org/10.1159/000381533
View articletitled, PRAME Expression and Its Clinical Relevance in Hodgkin's Lymphoma
Open the PDF for in another window
Numbers of CD8+PD-1+ and CD4+PD-1+ Cells in Peripheral Blood of Patients with Chronic Lymphocytic Leukemia Are Independent of Binet Stage and Are Significantly Higher Compared to Healthy Volunteers
Subject Area: Hematology , Oncology
Martin Novák; Vit Procházka; Peter Turcsányi; Tomáš Papajík
Acta Haematol (2015) 134 (4): 208–214. https://doi.org/10.1159/000381468
View articletitled, Numbers of CD8+PD-1+ and CD4+PD-1+ Cells in Peripheral Blood of Patients with Chronic Lymphocytic Leukemia Are Independent of Binet Stage and Are Significantly Higher Compared to Healthy Volunteers
Open the PDF for in another window
Romiplostim Treatment in Adults with Immune Thrombocytopenia of Varying Duration and Severity
Subject Area: Hematology , Oncology
Ann Janssens; Michael Tarantino; Robert J. Bird; Maria Gabriella Mazzucconi; Ralph V. Boccia; Maria Fernanda López Fernández; Tomas Kozak; Michael Steurer; Peter te Boekhorst; Kerry Dillingham; Georg Kreuzbauer; Paul Woodard
Acta Haematol (2015) 134 (4): 215–228. https://doi.org/10.1159/000381657
View articletitled, Romiplostim Treatment in Adults with Immune Thrombocytopenia of Varying Duration and Severity
Open the PDF for in another window

Brief Communication

The Feasibility and Efficacy of Dose-Adjusted Bortezomib, Melphalan and Dexamethasone for Transplantation-Ineligible Patients with Newly Diagnosed Multiple Myeloma
Subject Area: Hematology , Oncology
Kosuke Obama
Acta Haematol (2015) 134 (4): 229–230. https://doi.org/10.1159/000430836
View articletitled, The Feasibility and Efficacy of Dose-Adjusted Bortezomib, Melphalan and Dexamethasone for Transplantation-Ineligible Patients with Newly Diagnosed Multiple Myeloma
Open the PDF for in another window

Editorial Comment

Another Step Forward in Iron Chelation Therapy
Subject Area: Hematology , Oncology
Emanuele Angelucci
Acta Haematol (2015) 134 (4): 231–232. https://doi.org/10.1159/000431215
View articletitled, Another Step Forward in Iron Chelation Therapy
Open the PDF for in another window

Original Paper

Deferasirox Decreases Liver Iron Concentration in Iron-Overloaded Patients with Myelodysplastic Syndromes, Aplastic Anemia and Other Rare Anemias
Subject Area: Hematology , Oncology
Yutaka Kohgo; Akio Urabe; Yurdanur Kilinç; Leyla Agaoglu; Krzysztof Warzocha; Koichi Miyamura; Lay Cheng Lim; Sabine Glaser; Candace Wang; Wieslaw Wiktor-Jedrzejczak
Acta Haematol (2015) 134 (4): 233–242. https://doi.org/10.1159/000381893
View articletitled, Deferasirox Decreases Liver Iron Concentration in Iron-Overloaded Patients with Myelodysplastic Syndromes, Aplastic Anemia and Other Rare Anemias
Open the PDF for in another window

Brief Communication

A Novel Three-Way Variant t(8;13;21)(q22;q33;q22) in a Child with Acute Myeloid Leukemia with RUNX1/RUNX1T1: The Contribution of Molecular Approaches for Revealing t(8;21) Variants
Subject Area: Hematology , Oncology
Roberto R. Capela de Matos; Amanda F. De Figueiredo; Thomas Liehr; Eyad Alhourani; Mariana T. De Souza; Renata Binato; Raul C. Ribeiro; Maria Luiza Macedo Silva
Acta Haematol (2015) 134 (4): 243–245. https://doi.org/10.1159/000431073
View articletitled, A Novel Three-Way Variant t(8;13;21)(q22;q33;q22) in a Child with Acute Myeloid Leukemia with <strong><em>RUNX1/RUNX1T1</em></strong>: The Contribution of Molecular Approaches for Revealing t(8;21) Variants
Open the PDF for in another window

Editorial Comment

Chronic Myeloid Leukemia Monitoring after Imatinib Failure: Still More Questions than Answers
Subject Area: Hematology , Oncology
Rony Schaffel
Acta Haematol (2015) 134 (4): 246–247. https://doi.org/10.1159/000433413
View articletitled, Chronic Myeloid Leukemia Monitoring after Imatinib Failure: Still More Questions than Answers
Open the PDF for in another window

Original Paper

BCR-ABL1 Transcript Levels at 3 and 6 Months Are Better for Identifying Chronic Myeloid Leukemia Patients with Poor Outcome in Response to Second-Line Second-Generation Tyrosine Kinase Inhibitors after Imatinib Failure: A Report from a Single Institution
Subject Area: Hematology , Oncology
Beatriz Felicio Ribeiro; Bruna Rocha Vergílio; Eliana Cristina Martins Miranda; Maria Helena Almeida; Marcia Torresan Delamain; Rosana Antunes da Silveira; Carmino Antonio de Souza; Dulcinéia Martins Albuquerque; Andrey Dos Santos; Vagner Oliveira Duarte; Gislaine Borba Oliveira-Duarte; Irene Lorand-Metze; Katia Borgia Barbosa Pagnano
Acta Haematol (2015) 134 (4): 248–254. https://doi.org/10.1159/000430835
View articletitled, BCR-ABL1 Transcript Levels at 3 and 6 Months Are Better for Identifying Chronic Myeloid Leukemia Patients with Poor Outcome in Response to Second-Line Second-Generation Tyrosine Kinase Inhibitors after Imatinib Failure: A Report from a Single Institution
Open the PDF for in another window
Expression of Programmed Death 1 Ligand in Different Compartments of Chronic Lymphocytic Leukemia
Subject Area: Hematology , Oncology
Maciej Grzywnowicz; Agnieszka Karczmarczyk; Katarzyna Skorka; Malgorzata Zajac; Joanna Zaleska; Sylwia Chocholska; Waldemar Tomczak; Krzysztof Giannopoulos
Acta Haematol (2015) 134 (4): 255–262. https://doi.org/10.1159/000430980
View articletitled, Expression of Programmed Death 1 Ligand in Different Compartments of Chronic Lymphocytic Leukemia
Open the PDF for in another window

 

Contents Vol. 134, 2015
Subject Area: Hematology , Oncology
Acta Haematol (2015) 134 (4): I–IV. https://doi.org/10.1159/000441854
View articletitled, Contents Vol. 134, 2015
Open the PDF for in another window
Outcomes of Fedratinib in routine Treatment of ruxolitinib-resistant or refractory patients with Primary and post-polycythemia vera or essential thrombocythemia Myelofibrosis: A nationalwide retrospective study.
Beneficial effect of integrated nutritional interventions in patients with hematological diseases undergoing hematopoietic stem cell transplant
r/r LBCL: CAR-T-Zelltherapie im Behandlungsalltag
Prognostic value of the pretransplant fibrosis-4 (FIB-4) index on nonrelapse and overall mortality following unrelated single-unit cord blood transplantation in adults
  • Online ISSN 1421-9662
  • Print ISSN 0001-5792
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal